Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jun 18, 2025Jun 20, 2025Hastings Paul J
CEO
SellNkarta, Inc.NKTX$1.79$3,204-0.56%
Jan 15, 2025Jan 17, 2025Hastings Paul J
CEO
SellNkarta, Inc.NKTX$2.2$38,232-5.15%
Jun 18, 2024Jun 20, 2024Hastings Paul J
CEO
SellNkarta, Inc.NKTX$5.6$9,912-0.73%
Jun 13, 2024Jun 13, 2024Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$28.38$24,974-6.47%
Jan 16, 2024Jan 18, 2024Hastings Paul J
CEO
SellNkarta, Inc.NKTX$8.74$84,752-2.42%
Jun 20, 2023Jun 22, 2023Hastings Paul J
CEO
SellNkarta, Inc.NKTX$4.85$8,264-0.54%
Jun 05, 2023Jun 08, 2023Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$38.34$22,237-8.08%
May 15, 2023May 17, 2023Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$41.85$292,950-49.37%
Jan 17, 2023Jan 19, 2023Hastings Paul J
CEO
SellNkarta, Inc.NKTX$5.49$20,264-1.17%
Sep 28, 2022Sep 30, 2022Hastings Paul J
CEO
SellNkarta, Inc.NKTX$13.03$311,089-8.70%
Sep 21, 2022Sep 22, 2022Hastings Paul J
CEO
SellNkarta, Inc.NKTX$13.01$79,717-2.18%
Jul 11, 2022Jul 13, 2022Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$56.95$30,354-6.91%
Sep 29, 2021Oct 01, 2021Hastings Paul J
CEO
SellNkarta, Inc.NKTX$27.18$231,051-3.74%
Jun 21, 2021Jun 23, 2021Hastings Paul J
CEO
SellNkarta, Inc.NKTX$26.61$226,219-3.60%
Jun 04, 2021Jun 08, 2021Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$62.19$39,180-10.30%
Mar 30, 2021Apr 01, 2021Hastings Paul J
CEO
SellNkarta, Inc.NKTX$30.74$522,540-6.72%
Mar 05, 2021Mar 09, 2021Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$65.88$197,640-32.91%
Jun 04, 2020Jun 09, 2020Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$47.46$96,107-29.43%
Jun 04, 2019Jun 06, 2019Hastings Paul J
Dir
SellPacira Biosciences, Inc.PCRX$42.66$33,360-10.20%
Jun 04, 2018Jun 07, 2018Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$33.9$26,137-21.92%
Oct 10, 2017Oct 12, 2017Hastings Paul J
COB
CEO
SellOncomed Pharmaceuticals IncOMED$4.24$5,931-0.35%
Aug 22, 2017Aug 25, 2017Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$36.15$37,741-22.88%
Apr 04, 2017Apr 05, 2017Hastings Paul J
COB
CEO
SellOncomed Pharmaceuticals IncOMED$9.06$58,625-1.78%
Jan 05, 2017Jan 09, 2017Hastings Paul J
COB
CEO
SellOncomed Pharmaceuticals IncOMED$8.34$356,559-10.56%
Jun 06, 2016Jun 08, 2016Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$46.95$53,335-39.82%
Jun 07, 2016Jun 08, 2016Hastings Paul J
Dir
SellRelypsa IncRLYP$19.32$19,573-28.88%
Feb 17, 2016Feb 23, 2016Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$60$180,000-51.26%
Jan 06, 2016Jan 09, 2016Hastings Paul J
COB
CEO
SellOncomed Pharmaceuticals IncOMED$22.28$53,731-0.69%
Nov 20, 2015Nov 24, 2015Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$60$180,000-51.26%
Aug 17, 2015Aug 20, 2015Hastings Paul J
Dir
SellPacira Pharmaceuticals, Inc.PCRX$60.02$180,060-51.26%